Prognostic Value of Specific High-Risk Cytogenetic Abnormalities and Ethnicity in Outcomes after Autologous Stem Cell Transplant in Multiple Myeloma

被引：0
|
作者：
Basher, Fahmin [1 ,2 ]
Sanchez, Sandra [3 ]
Hoffman, James E. [4 ]
Lekakis, Lazaros J. [4 ]
Pereira, Denise [5 ]
机构：
[1] Duke Univ, Med Ctr, Dept Med, Miami, FL USA
[2] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA
[3] Univ Miami, Sylvester Comprehens Canc Ctr, Dept Pathol & Lab Med, Div Hematopathol, Miami, FL USA
[4] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA
[5] Univ Miami, Sylvester Comprehens Canc Ctr, Div Transplantat & Cellular Therapy, Miami, FL USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-154303
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5041
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Outcomes after delayed and second autologous stem cell transplant in patients with relapsed multiple myeloma
    Lemieux, Christopher
    Muffly, Lori S.
    Iberri, David J.
    Craig, Juliana K.
    Johnston, Laura J.
    Lowsky, Robert
    Shiraz, Parveen
    Rezvani, Andrew R.
    Frank, Matthew J.
    Weng, Wen-Kai
    Meyer, Everett
    Shizuru, Judith A.
    Arai, Sally
    Liedtke, Michaela
    Negrin, Robert S.
    Miklos, David B.
    Sidana, Surbhi
    BONE MARROW TRANSPLANTATION, 2021, 56 (11) : 2664 - 2671
  • [22] Outcomes of Tandem Hematopoietic Stem Cell Autologous Transplant in High-Risk Myeloma Patients: A Single-Center Experience
    Philip, Shona
    Lam, Selay
    Phua, Chai Wye
    Louzada, Martha L.
    Xenocostas, Anargyros
    Deotare, Uday
    BLOOD, 2021, 138
  • [23] AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION IN HIGH-RISK MULTIPLE-MYELOMA
    REIFFERS, J
    MARIT, G
    BOIRON, JM
    BRITISH JOURNAL OF HAEMATOLOGY, 1989, 72 (02) : 296 - 297
  • [24] The Impact of Autologous Stem Cell Transplantation on the Genetics of High-Risk Relapsed Multiple Myeloma
    Shahin, Mohamed
    Pawlyn, Charlotte
    Weinhold, Niels
    Ashby, Timothy Cody
    Walker, Brian A.
    Wardell, Christopher P.
    Cairns, David
    Menzies, Tom
    Gregory, Walter Martin
    Kaiser, Martin F.
    Cook, Gordon
    Drayson, Mark T.
    Owen, Roger G.
    Jackson, Graham
    Davies, Faith E.
    Morgan, Gareth J.
    Jones, John R.
    BLOOD, 2022, 140 : 4232 - 4233
  • [25] High-risk cytogenetic abnormalities in multiple myeloma: PETHEMA-GEM experience
    Rodriguez-Otero, Paula
    Gonzalez-Calle, Veronica
    Calasanz, Maria-Jose
    Cedena, Teresa
    Puig, Noemi
    Martinez-Lopez, Joaquin
    Rosinol, Laura
    Hernandez Garcia, Miguel Teodoro
    Isabel Teruel, Ana
    Gironella, Mercedes
    Oriol, Albert
    de la Rubia, Javier
    Pilar Gonzalez-Rodriguez, Ana
    Bargay, Joan
    de Arriba de la Fuente, Felipe
    Palomera, Luis
    Gonzalez-Perez, Marta-Sonia
    Sureda Balari, Anna
    Lahuerta Palacios, Juan Jose
    Blade, Joan
    San-Miguel, Jesus
    Mateos, Maria-Victoria
    Gutierrez, Norma
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S241 - S242
  • [26] High-risk cytogenetic abnormalities in multiple myeloma: PETHEMA-GEM experience
    Gonzalez-Calle, Veronica
    Rodriguez-Otero, Paula
    Calasanz, Maria J.
    Guijarro, Manuela
    Martinez-Lopez, Joaquin
    Rosinol, Laura
    Hernandez, Miguel T.
    Teruel, Ana I.
    Gironella, Mercedes
    Oriol, Albert
    de la Rubia, Javier
    Gonzalez-Rodriguez, Ana P.
    Bargay, Joan
    de Arriba, Felipe
    Palomera, Luis
    Gonzalez-Perez, Marta-Sonia
    Sureda, Anna
    Ocio, Enrique
    Lahuerta, Juan J.
    Blade, Joan
    San Miguel, Jesus F.
    Mateos, Maria V.
    Gutierrez, Norma C.
    HEMASPHERE, 2024, 8 (12):
  • [27] Complete response after autologous stem cell transplant in multiple myeloma
    Kumar, Lalit
    Iqbal, Nida
    Mookerjee, Anjali
    Verma, Rakesh Kumar
    Sharma, Om D.
    Batra, Atul
    Pramanik, Raja
    Gupta, Ritu
    CANCER MEDICINE, 2014, 3 (04): : 939 - 946
  • [28] Management of Relapsed Multiple Myeloma after Autologous Stem Cell Transplant
    Holstein, Sarah A.
    Richardson, Paul G.
    Laubach, Jacob P.
    McCarthy, Philip L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (05) : 793 - 798
  • [29] Elotuzumab As Post-Autologous Stem Cell Transplant Consolidation in Patients with High-Risk Myeloma
    Gadi, Nikhita
    Schmidt, Linda
    Ahn, Jaeil
    Wu, Tianmin
    Rowley, Scott D.
    Paleoudis, Elli Gourna
    Donato, Michele L.
    Vesole, David H.
    Goldberg, Stuart L.
    Siegel, David S.
    Biran, Noa
    BLOOD, 2019, 134
  • [30] Racial Differences in High-Risk Cytogenetic Mutations and Outcomes in Multiple Myeloma
    Derman, Ben A.
    Chernoff, Meytal
    Jakubowiak, Andrzej
    Chiu, Brian C. -H.
    BLOOD, 2019, 134
12345